Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,975 | 29,319 | 17,510 | 19,582 | 12,654 |
| Receivables | 1,980 | 2,025 | 1,172 | 653 | 297 |
| TOTAL | $27,331 | $32,915 | $19,788 | $22,332 | $15,507 |
| Non-Current Assets | |||||
| PPE Net | 454 | 361 | 50 | 40 | 3 |
| Other Non-Current Assets | 1,051 | 1,072 | 87 | 103 | 57 |
| TOTAL | $1,505 | $1,432 | $137 | $143 | $59 |
| Total Assets | $28,836 | $34,348 | $19,925 | $22,475 | $15,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,854 | 5,623 | 3,722 | 2,826 | 2,396 |
| TOTAL | $3,902 | $5,657 | $3,722 | $2,826 | $2,396 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,056 | 1,131 | 66 | 63 | 22 |
| TOTAL | $1,043 | $1,059 | $N/A | $N/A | $N/A |
| Total Liabilities | $4,945 | $6,716 | $3,722 | $2,826 | $2,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,450 | 26,414 | 26,396 | 19,867 | 16,287 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -63,063 | -58,670 | -53,411 | -48,322 | -44,041 |
| Other shareholders' equity | 17 | -294 | -167 | -178 | -76 |
| TOTAL | $23,891 | $27,632 | $16,203 | $19,649 | $13,171 |
| Total Liabilities And Equity | $28,836 | $34,348 | $19,925 | $22,475 | $15,567 |